Loading…
← CockpitCompetitor Analysis › 002382.SZ Blue Sail Medical Co., Ltd. Class AOpen in the cockpit ↗

Blue Sail Medical Co., Ltd. Class A002382.SZCompetitor analysis, valuation and peers

China · CNY·Industrials›Miscellaneous Manufacturing
Momentum neutral 56
Mkt cap
$801M
US dollars, full cap
Free float
67%
of shares outstanding
$/day
$11.5M
20-day average traded
Fwd P/E
10.9×
forward earnings
ROIC−WACC
+0.8 pp
WACC 5.0%
Hurdle
-1 pp
Req g minus delivered
Next earnings
159 days
26 Apr 2027
Close · CNYCN¥5.32
1D-0.8%
1W-4.0%
1M-13.5%
3M-11.8%
6M-21.4%
YTD-5.0%
1Y-2.7%
ATR %3.2%
52w lowhigh40.3% off high

What Blue Sail Medical does

Employees: 8,962

Blue Sail Medical at a glance

Size Blue Sail Medical (002382.SZ) is a China Industrials company (Miscellaneous Manufacturing) with a market value of $801M, the 2582nd largest of 4,790 China companies the cockpit tracks. Shares closed at CN¥5.32 on 18 Nov 2026.

Performance Over six months the shares fell 21.4%, against -23.5% for the median peer and -20.0% for the China market (cap-weighted) — 9th highest of 21 in its peer set.

Growth Revenue grew 22.8% over the last twelve months (peer median +4.3%); the operating margin is 7.0% (peer median 7.1%).

Valuation It trades at 10.9× forward earnings against a peer median of 24.7× (2nd cheapest of 14).

Price implies For today's price to make sense, revenue must grow about -7% a year for seven years (Req g). Recent delivered growth is -6%, so the hurdle is -1 pp: the price already allows for a slowdown.

Capital Return on invested capital runs 0.8 points above its cost of capital (5.0% WACC).

Next results Next results expected around 26 Apr 2027 (exchange calendar; dates can move).

Relative performance

809010021 May 202621 Aug 202618 Nov 2026002382.SZ 80Peer median 75
Six months, rebased to 100: Blue Sail Medical against the median of its 20 peers (local-currency closes).

Blue Sail Medical financials

Reported figures in CNY; fiscal year ends 2025-12-31. TTM = trailing twelve months.
TTMFY2025FY2024FY2023FY2022
RevenueCN¥7.10BCN¥5.73BCN¥6.24BCN¥4.92BCN¥4.89B
Revenue growth—-8%+27%+1%—
Gross profitCN¥2.23BCN¥787MCN¥921MCN¥502MCN¥386M
EBITDAn/aCN¥254MCN¥326M-CN¥27.7M-CN¥141M
Net income-CN¥315M-CN¥759M-CN¥446M-CN¥568M-CN¥372M
Free cash flowCN¥526M-CN¥73.1M-CN¥632M-CN¥816M-CN¥364M
Capital expenditureCN¥399MCN¥553MCN¥774MCN¥774MCN¥897M
Total debtCN¥2.71BCN¥5.45BCN¥5.18BCN¥4.04BCN¥3.21B

Quarterly statements and history in the cockpit →

Blue Sail Medical competitor charts

The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.

Performance: 6-month against 1-month return

-60%-40%-20%0%-20%-10%0%6033114583300234300232300196300868RHIM600525GENAP4688151605128001356002108FINPIPE300587603657301000INH002382.SZ6-month return →1-month return →
Up and to the right = strong over both horizons. Blue Sail Medical is the large dot.

Fundamentals: revenue growth against valuation

0%+10%+20%20×40×60×6033114583300232300196RHIMGENAP4605128300587603657301000INH002382.SZRevenue growth (TTM) →Forward P/E →
Further right = faster growth; higher = more expensive. The dashed lines are the peer medians. Blue Sail Medical is the large dot.

Capital: growth delivered against growth the price implies

0%+20%+40%0%20%40%4583300232300196RHIM600525GENAP4688151605128002632FINPIPEINH002382.SZGrowth delivered (Del g) →Growth the price implies (Req g, 7 yrs) →
Above the diagonal = the price needs more growth than the company has been delivering; below = the price already allows for a slowdown. Blue Sail Medical is the large dot.

Blue Sail Medical competitors and peer comparison

How Blue Sail Medical compares with its peers

Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.

Blue Sail Medical against its 20 peers (data as of 18 Nov 2026)
Measure002382.SZPeer medianRank in peer set
1-month return-13.5%-8.2%5th lowest of 21
6-month return-21.4%-23.5%9th highest of 21
Distance from 52-week high-40.3%-38.7%11th highest of 21
Revenue growth (TTM)+22.8%+4.3%2nd highest of 21
Operating margin7.0%7.1%11th highest of 21
Forward P/E10.9×24.7×2nd cheapest of 14
Growth the price implies (Req g, 7 yrs)-7.2%5.8%3rd least demanding of 13
Growth delivered (Del g)-6.1%+4.3%2nd lowest of 13
Hurdle (Req g minus delivered)-1.1 pp+0.4 pp6th least demanding of 13
ROIC minus cost of capital+0.8 pp-3.5 pp8th highest of 21

Peer table

Peer set: Industry: the same industry and sector in any market, nearest in size
CompanyMarketMarket cap6M returnRevenue growthOp. marginForward P/EReq gDelivered g
Blue Sail Medical 002382.SZChina$801M-21%+23%7%10.9×-7.2%-6.1%
Zhejiang Goldensea Hi-Tech 603311.SSChina$791M-3%+3%7%57.4×n/an/a
Apex Dynamics 4583.TWTaiwan$813M-55%+14%33%28.6×0.7%+1.1%
Zhejiang Kaier New Materials 300234.SZChina$774M+43%-17%-9%n/an/an/a
Unilumin 300232.SZChina$772M-23%+1%0%31.5×5.9%+10.3%
Jiangsu Changhai Composite Materials 300196.SZChina$838M-31%+3%11%16.5×2.7%+9.0%
Shenzhen Jame Technology 300868.SZChina$764M-56%+8%-7%n/an/an/a
RHI Magnesita India RHIM.NSIndia$763M-10%+4%8%25.2×25.2%+24.1%
Changyuan Technology 600525.SSChina$760M-24%+7%-7%n/a-12.9%+5.1%
Genuit GEN.LUnited Kingdom$851M0%+4%12%12.0×12.1%+8.6%
Riverstone AP4.SISingapore$880M-22%-4%25%16.4×3.8%-12.8%
Hubei Huaqiang High-Tech 688151.SSChina$718M-29%+13%-5%n/a41.6%-5.6%
Shanghai Yanpu Precision Technology (Group) 605128.SSChina$897M-19%+3%9%24.7×13.8%+25.0%
Fuling Technology 001356.SZChina$704M-33%+17%6%n/an/an/a
Cangzhou Mingzhu Plastic 002108.SZChina$920M-33%+14%5%n/an/an/a
Daoming Optics & Chemical 002632.SZChina$676M-33%-10%12%n/a5.8%+3.3%
Finolex Industries FINPIPE.NSIndia$958M-13%+3%14%16.8×13.5%+3.5%
Zhejiang Tiantie Science & Technology 300587.SZChina$665M-46%+24%-4%12.4×n/an/a
Jinhua Chunguang Technology 603657.SSChina$662M+13%+22%-4%43.5×n/an/a
Shanghai Hajime Advanced Material Technology 301000.SZChina$992M-28%+4%16%41.1×n/an/a
INDUS INH.DEGermany$992M+12%+15%15%6.7×-10.4%+2.2%

Questions

Which companies are Blue Sail Medical's closest peers?
The cockpit's peer set: Zhejiang Goldensea Hi-Tech (603311.SS), Apex Dynamics (4583.TW), Zhejiang Kaier New Materials (300234.SZ), Unilumin (300232.SZ), Jiangsu Changhai Composite Materials (300196.SZ), Shenzhen Jame Technology (300868.SZ), RHI Magnesita India (RHIM.NS), Changyuan Technology (600525.SS).
Is Blue Sail Medical expensive compared with its peers?
On forward p/e it trades at 10.9× against a peer median of 24.7×, 2nd cheapest of 14 in its peer set. For today's price to make sense, revenue must grow about -7% a year for seven years (Req g). Recent delivered growth is -6%, so the hurdle is -1 pp: the price already allows for a slowdown.
How has Blue Sail Medical stock performed?
Over six months to 18 Nov 2026 the shares returned -21.4% against -23.5% for the median peer; over one year -2.7%.

How these numbers are made. Returns are close-to-close in local currency. Revenue growth and margins are trailing twelve months. Req g is the revenue growth that today's enterprise value requires for seven years at the company's own cost of capital; Delivered g is what it actually grew; the gap is the hurdle (honest precision about ±8 points, so read the ranking more than the decimal). No fair values, price targets or analyst ratings are shown, by design. Method and validation.